Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T10:28:11.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Updated naming to proper capitalization for the condition and bumped release to v3.1.0.
    Difference
    0.4%
    Check dated 2025-09-28T03:18:55.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. This indicates a simple version upgrade with minor UI cleanup.
    Difference
    0.2%
    Check dated 2025-09-13T17:39:50.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:25:16.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility information and a broader range of medical topics related to cancer and immunology, while removing some specific location details and previous resources on lymphoma.
    Difference
    6%
    Check dated 2025-08-30T12:05:53.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:41:48.000Z thumbnail image

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.